| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/06/2002 | EP0861077B1 Hemoregulatory compounds |
| 02/06/2002 | EP0734386B1 Platelet activating factor antagonists: imidazopyridine indoles |
| 02/06/2002 | CN1334816A Triazolo (4,5-D) pyrimidine compounds |
| 02/06/2002 | CN1334809A Nonsteroidal antiinflammatories |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/06/2002 | CN1334730A Vitronectin receptor antagonist |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/06/2002 | CN1334110A Chinese medicine for treating blood viscosity and its preparing process |
| 02/05/2002 | US6344596 Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals |
| 02/05/2002 | US6344566 Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrolidine-1-yl)ethyl]-2,2-diphenylacetamide |
| 02/05/2002 | US6344551 Contulakin-G, analogs thereof and uses therefor |
| 02/05/2002 | US6344486 Anticoagulants |
| 02/05/2002 | US6344468 Substituted isoindolones and their use as cyclic GMP modulators in medicaments |
| 02/05/2002 | US6344466 Antithrombotic activity, use in inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, anticoagulants |
| 02/05/2002 | US6344456 Piperazinone derivatives and their uses |
| 02/05/2002 | US6344451 Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344321 Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
| 02/05/2002 | CA2058635C Treatment of thrombotic events |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008295A1 Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008239A1 Novel disaccharides with anti-arthritic action |
| 01/31/2002 | WO2002008219A2 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 01/31/2002 | WO2002008217A2 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | WO2002007777A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS |
| 01/31/2002 | WO2002007744A1 Essential oil combination and therapeutic uses thereof |
| 01/31/2002 | WO2002007717A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001079158A3 Compounds for modulating cell proliferation |
| 01/31/2002 | WO2001064870A3 Mutated cyclin g1 protein |
| 01/31/2002 | WO2001062775A3 Novel antiarrhythmic peptides |
| 01/31/2002 | WO2001044284A3 Chimeric natriuretic peptides |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001008634A3 Polynucleotide encoding a human serine protease |
| 01/31/2002 | WO2000059941A9 Purposeful movement of human migratory cells away from an agent source |
| 01/31/2002 | US20020013357 Valdecoxib compositions |
| 01/31/2002 | US20020013347 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/31/2002 | US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 01/31/2002 | US20020013339 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 01/31/2002 | US20020013334 HMG-CoA reductase inhibitors and method |
| 01/31/2002 | US20020013325 Useful as glycoprotein IIb/IIIa antagonists for prophylaxis thrombosis, therapy of atheroschlerosis, arterioschlerosis, acute myocardial infarction, chronic stable angina, unstable angina, transient ischemic attacks and strokes |
| 01/31/2002 | US20020013314 For treating or preventing thrombosis |
| 01/31/2002 | US20020013279 Hematopoietic stimulation |
| 01/31/2002 | US20020013278 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 01/31/2002 | US20020013267 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 01/31/2002 | US20020012957 Plasma-like solution |
| 01/31/2002 | US20020012906 Method for kidney disease treatment by drug intervention |
| 01/31/2002 | US20020012723 Containing sugar to provide freezing and thawing stability; foods, drinks; treatment of anemia |
| 01/31/2002 | US20020012715 Protecting cell from damage caused by free radicals by administering lipophilic antioxidant comprising vitamin E, beta carotene, extract of Lycopersicum esculentum, hydrophilic antioxidant comprising vitamin c, extract of vitis vinifera |
| 01/31/2002 | US20020012662 Method of treating sickle cell disease or thalassemia |
| 01/31/2002 | US20020012661 Methods for introducing genes into mammalian subjects |
| 01/31/2002 | DE10035144A1 Cyclische Aminosäurederivate Cyclic amino acid derivatives |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2416358A1 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type i interferons |
| 01/31/2002 | CA2415585A1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/30/2002 | EP1176201A2 Platelet-specific chimeric immunoglobulin |
| 01/30/2002 | EP1176149A1 Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine |
| 01/30/2002 | EP1176146A1 Carbamoyl tetrahydropyridine derivatives |
| 01/30/2002 | EP1175911A2 Uses of recombinant colony stimulating factor-1 for treatment of leukopenia |
| 01/30/2002 | EP1175906A1 Blood flow improvers and thrombosis preventives or remedies comprising glucosamine |
| 01/30/2002 | EP1175900A2 Use of growth hormone secretagogues for improvement of fucnctional health status |
| 01/30/2002 | EP1175503A1 49 human secreted proteins |
| 01/30/2002 | EP1175446A1 Human antibodies that bind human il-12 and methods for producing |
| 01/30/2002 | EP1175440A1 48 human secreted proteins |
| 01/30/2002 | EP1175405A1 LACTAM INHIBITORS OF FXa AND METHOD |
| 01/30/2002 | EP1175246A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 01/30/2002 | EP1175223A2 Methods and compositions for modulating an immune response |
| 01/30/2002 | EP0819136B1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
| 01/30/2002 | EP0605462B1 New isosteric peptides |
| 01/30/2002 | CN1333772A Imidazo (4,5-c)-pyridine-4-on-derivatives |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/30/2002 | CN1333757A Quinazoline derivatives as medicaments |
| 01/30/2002 | CN1333688A Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 01/30/2002 | CN1333047A Yunnan pine nut extract and preparation process and use thereof |
| 01/30/2002 | CN1078472C Application of theachrome in preparing medicine for plateau erythrocytosis |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342581 Genetic engineering and expression of polynucleotides and polypeptides; vectors, cells, antibodies for diagnosis and disease treatment |
| 01/29/2002 | US6342531 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 01/29/2002 | US6342510 Antiinflammatory agents and enzyme inhibitors |
| 01/29/2002 | US6342505 Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1 |
| 01/29/2002 | US6342477 Remedies for thrombocytopenia |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/29/2002 | US6342202 Injecting into blood vessel composition consisting essentially of polyvinyl acetate having molecular weight of at least about 50,000, contrast agent and biocompatible solvent to precipitate polymer and embolize blood vessel |
| 01/29/2002 | CA2145296C Benzenealkanoic acids for cardiovascular diseases |
| 01/29/2002 | CA2066374C Solution for perfusing primates |
| 01/27/2002 | CA2353768A1 Use of growth hormone secretagogues for improvement of functional health status |
| 01/24/2002 | WO2002006307A1 Reduced fk228 and use thereof |
| 01/24/2002 | WO2002006271A1 Pyrimidine derivatives |
| 01/24/2002 | WO2002006261A1 Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect |
| 01/24/2002 | WO2002006254A1 Tetrazole derivatives |
| 01/24/2002 | WO2002006248A2 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 01/24/2002 | WO2002006234A1 Sulfone derivatives, process for their production and use thereof |
| 01/24/2002 | WO2002005857A2 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | WO2002005796A2 Use of a spla2 inhibitor for the treatment of sepsis |